| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/13/1999 | EP0890640A2 G-CSF analog compositions and methods |
| 01/13/1999 | EP0889964A1 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/13/1999 | EP0889955A1 Recombinant phages |
| 01/12/1999 | US5859204 Non-antigenic, non-immunogenic superior coagulant human/porcine hybrid by site directed mutagenesis; hemophilia |
| 01/12/1999 | US5859201 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/12/1999 | US5859193 Synthetic DNA derived recombinant HIV antigens |
| 01/12/1999 | US5859192 Contain amino acid sequences that reacts specifically with a monoclonal antibody secreted by a strain of hybridoma; capable of ensuring transmission of a signal from one cell type to another which may be contiguous or proximal |
| 01/12/1999 | US5858752 Pure alpha1-acid glycoprotein or fusion polypeptide which has been fucosylated; for protection against septic shock or septiciemia |
| 01/12/1999 | US5858677 Protein D--an IgD-binding protein of haemophilus influenzae |
| 01/12/1999 | US5858368 Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein |
| 01/12/1999 | US5858366 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding |
| 01/12/1999 | US5858347 Therapeutic methods using fusion proteins between interleukin-3 (IL-3) variants and other hematopoietic factors |
| 01/12/1999 | CA2153896C G-csf analog compositions and methods |
| 01/12/1999 | CA2070503C A-c-b proinsulin, method of manufacturing and using same, and intermediates in insulin production |
| 01/07/1999 | WO1999000494A2 Cell activation process and reagents therefor |
| 01/07/1999 | WO1998045427A3 Insulin-like growth factor agonist peptides |
| 01/07/1999 | WO1998042740A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/07/1999 | EP0888454A1 Expression and secretion of heterologous polypeptides from caulobacter |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888385A2 Uses of gdnf and gdnf receptor |
| 01/07/1999 | EP0888384A2 Conjugate for modifying interactions between proteins |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0651818B1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
| 01/05/1999 | US5856452 Oil bodies and associated proteins as affinity matrices |
| 01/05/1999 | US5856447 Vaccine against lyme disease |
| 01/05/1999 | US5856302 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 01/05/1999 | US5856297 Human C3b/C4b receptor (CR1) |
| 01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant. |
| 01/05/1999 | US5855891 Ichimeric papillomavirus-like particles |
| 01/05/1999 | CA2045640C Receptor membranes and ionophore gating |
| 12/30/1998 | WO1998059059A1 Expression system for production of therapeutic proteins |
| 12/30/1998 | EP0887410A2 DNA encoding a plasminogen activating protein |
| 12/30/1998 | EP0553244B1 Targeted immunostimulation with bispecific reagents |
| 12/30/1998 | CN1203603A Therapeutic compounds comprised of anti-FC receptor antibodies |
| 12/30/1998 | CA2294119A1 Expression system for production of therapeutic proteins |
| 12/29/1998 | US5854392 β APP-C100 receptor |
| 12/29/1998 | US5854044 Recombinant pseudomonas exotoxin with increased activity |
| 12/29/1998 | US5854027 Process for improving the stability of antibodies |
| 12/29/1998 | US5854016 Creba Isoform |
| 12/29/1998 | US5854001 Hepatitis C virus fusion proteins |
| 12/29/1998 | US5853702 Penicillium purpurogenum mutanases and nucleic acids encoding same |
| 12/29/1998 | CA2129554C Recombinant antibodies specific for tnf-.alpha. |
| 12/29/1998 | CA1340289C Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies |
| 12/29/1998 | CA1340288C Generation and selection of novel binding proteins |
| 12/23/1998 | WO1998058062A1 Apo-2DcR |
| 12/23/1998 | WO1998058053A1 Human receptor tyrosine kinase, kdr |
| 12/23/1998 | WO1998042830A3 Noey2 gene compositions and methods of use |
| 12/23/1998 | EP0885299A1 Wsx receptor and ligands |
| 12/23/1998 | EP0885244A1 Peptide immunogens for vaccination against and treatment of allergy |
| 12/23/1998 | EP0885012A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 12/23/1998 | EP0473721B1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 12/23/1998 | CA2293740A1 Apo-2dcr, a tnf-related receptor |
| 12/23/1998 | CA2293723A1 Human receptor tyrosine kinase, kdr |
| 12/22/1998 | US5852176 Antibodies to receptors for human interleukin-12 |
| 12/22/1998 | US5851828 Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells |
| 12/22/1998 | US5851827 DNA encoding clostridium perfringens alpha-toxin peptides |
| 12/22/1998 | US5851801 Method of preparing polypeptide binding compositions derived from immunoglobulin variable regions |
| 12/22/1998 | US5851791 Ubiquitin conjugating enzyme (E2) fusion proteins |
| 12/22/1998 | US5851787 Nucleic acid encoding amyloid precursor-like protein and uses thereof |
| 12/22/1998 | US5851528 Methods of inhibiting complement activation |
| 12/20/1998 | CA2218852A1 Expression system for production of therapeutic proteins |
| 12/17/1998 | WO1998056928A1 Increased production of proteins by using chaperone-like proteins |
| 12/16/1998 | EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML) |
| 12/16/1998 | EP0884329A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 12/16/1998 | EP0883688A1 Adapter molecules for targeting viral particles to cells |
| 12/16/1998 | EP0731806A4 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 12/16/1998 | EP0652962B1 Expression of recombinant fusion proteins in attenuated bacteria |
| 12/16/1998 | EP0575553B1 Recombinant hybrid porin epitopes |
| 12/15/1998 | US5849876 Hybridomas producing monoclonal antibodies to new mucin epitopes |
| 12/15/1998 | US5849871 α-melanocyte stimulating hormone receptor |
| 12/15/1998 | US5849869 Delta fragments and derivatives and methods based thereon |
| 12/15/1998 | US5849863 Cytolytic bradykinin antagonists |
| 12/15/1998 | US5849688 Transgenic,cross-linked hemoglobin |
| 12/15/1998 | US5849600 Diagnostic assays for Alzheimer's disease |
| 12/15/1998 | US5849506 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 12/15/1998 | US5849485 Liver enriched transcription factor |
| 12/15/1998 | CA1340245C Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same |
| 12/15/1998 | CA1340244C Dnas and processes for their preparation, novel plasmids comprising themnovel polypeptides and processes for their preparation and novel anti-tumor agents comprising said polypeptides |
| 12/15/1998 | CA1340237C Process for isolating basic proteins from protein mixtures containing such basic proteins |
| 12/15/1998 | CA1340233C Antigenic epitopes of immunoglobulin e present on b cell but not basophil surface |
| 12/15/1998 | CA1340201C Receptors for immune complexes |
| 12/10/1998 | WO1998055623A1 Type-1 ribosome-inactivating protein |
| 12/10/1998 | WO1998055621A1 Ntn-2 member of tnf ligand family |
| 12/10/1998 | WO1998055620A1 Ntn-2 member of tnf ligand family |
| 12/10/1998 | WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 12/10/1998 | WO1998055136A1 Fsh-releasing peptides |
| 12/10/1998 | CA2293664A1 Fsh-releasing peptides |
| 12/10/1998 | CA2292899A1 Ntn-2 member of tnf ligand family |
| 12/10/1998 | CA2292835A1 Ntn-2 member of tnf ligand family |
| 12/09/1998 | EP0882131A1 Polypeptides having mutanase activity and nucleic acids encoding same |
| 12/09/1998 | EP0882128A1 Cell-based assay |
| 12/09/1998 | EP0882123A1 Process for removal or bleaching of soiling or stains from cellulosic fabric |
| 12/09/1998 | EP0882065A2 Novel human metabotropic glutamate receptor |
| 12/08/1998 | US5847085 Modified protein C and methods of use thereof |
| 12/08/1998 | US5847082 Terminal complement inhibitor fusion proteins |